Copaxone needles to treat multiple sclerosis. Photo via Shutterstock

• Michael Sela, Ruth Arnon and Dvora Teitelbaum begin experimenting with synthetic substances to reduce the symptoms associated with MS. Thirty years later, the FDA approves Copaxone, the drug the three developed along with Teva Pharmaceuticals.

• Ben-Gurion University of the Negev opens.

• Israel successfully overcomes attacks by Egypt, Jordan and Syria in the Six-Day War. In the wake of this unlikely victory, the historical and religious sites in the Old City of Jerusalem are rebuilt and become the most popular tourist destination in Israel.